Literature DB >> 1882639

Neuromyopathy and restrictive cardiomyopathy with accumulation of intermediate filaments: a clinical, morphological and biochemical study.

E Bertini1, C Bosman, E Ricci, S Servidei, R Boldrini, M Sabatelli, G Salviati.   

Abstract

The clinical, morphological and biochemical findings of a sporadic case, showing accumulation of desmin-type intermediate filaments in skeletal muscle and myocardium are described. Desmin storage was demonstrated by immunofluorescence, sodium dodecyl sulfate gel electrophoresis and two-dimensional gel electrophoresis. These findings are in agreement with those of Rappaport et al. (FEBS lett. 231:421-425, 1989). A sensory-motor polyneuropathy was established by electrophysiological studies and, ultrastructurally, intramuscular nerves showed accumulation of neurofilaments and neurotubules with formation of axonal spheroids. These findings are discussed considering all previous reports with related conditions.

Entities:  

Mesh:

Year:  1991        PMID: 1882639     DOI: 10.1007/bf00296373

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  26 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Axonal filamentous spheroids associated with cardiomyopathy with "targetoid fibers". I. Clinical, histologic, and electron microscopic studies.

Authors:  H M Liu; M Gumbinas
Journal:  Neurology       Date:  1974-06       Impact factor: 9.910

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  [A new familial muscular disorder demonstrated by the intra-sarcoplasmic accumulation of a granulo-filamentous material which is dense on electron microscopy (author's transl)].

Authors:  M Fardeau; J Godet-Guillain; F M Tome; H Collin; S Gaudeau; C Boffety; P Vernant
Journal:  Rev Neurol (Paris)       Date:  1978 Jun-Jul       Impact factor: 2.607

5.  An unusual familial cardiomyopathy characterized by aberrant accumulations of desmin-type intermediate filaments.

Authors:  M E Stoeckel; M Osborn; A Porte; A Sacrez; A Batzenschlager; K Weber
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

6.  [Familial cardiomyopathy: a study of two families with myocardial and skeletal muscle biopsies].

Authors:  A Sacrez; A Porte; A Batzenschlager; T De Barsy; F Wolff; D Grison; L Stoeckel; P Ferrière
Journal:  Arch Mal Coeur Vaiss       Date:  1979-07

7.  Myopathy associated with desmin type intermediate filaments. An immunoelectron microscopic study.

Authors:  J F Pellissier; J Pouget; C Charpin; D Figarella
Journal:  J Neurol Sci       Date:  1989-01       Impact factor: 3.181

8.  Subsarcolemmal vermiform deposits in skeletal muscle, associated with familial cardiomyopathy: report of two cases of a new entity.

Authors:  A Calderon; L E Becker; E G Murphy
Journal:  Pediatr Neurosci       Date:  1987

9.  Myopathy with respiratory failure and typical myofibrillar lesions.

Authors:  L Edström; L E Thornell; J Albo; S Landin; M Samuelsson
Journal:  J Neurol Sci       Date:  1990-05       Impact factor: 3.181

10.  A form of congenital muscular dystrophy.

Authors:  H H Goebel; H G Lenard; U Langenbeck; B Mehl
Journal:  Brain Dev       Date:  1980       Impact factor: 1.961

View more
  10 in total

1.  Lower active force generation and improved fatigue resistance in skeletal muscle from desmin deficient mice.

Authors:  J Balogh; Z Li; D Paulin; A Arner
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

2.  Hereditary myopathy of the diaphragmatic muscles in Holstein-Friesian cattle.

Authors:  H Furuoka; T Doi; N Nakamura; I Inada; S Osame; T Matsui
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

3.  Restrictive cardiomyopathies in childhood. Etiologies and natural history.

Authors:  S W Denfield; G Rosenthal; R J Gajarski; J T Bricker; K O Schowengerdt; J K Price; J A Towbin
Journal:  Tex Heart Inst J       Date:  1997

4.  Desmin and vimentin as markers of regeneration in muscle diseases.

Authors:  A Gallanti; A Prelle; M Moggio; P Ciscato; N Checcarelli; M Sciacco; A Comini; G Scarlato
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 5.  Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease.

Authors:  Lev G Goldfarb; Marinos C Dalakas
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

6.  Desmin myopathy with cardiomyopathy.

Authors:  C H Cameron; M Mirakhur; I V Allen
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

7.  Cytoplasmic body myopathy: familial cases with accumulation of desmin and dystrophin. An immunohistochemical, immunoelectron microscopic and biochemical study.

Authors:  A Caron; F Viader; B Lechevalier; F Chapon
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  Reducing body myopathy and desmin storage in skeletal muscle: morphological and biochemical findings.

Authors:  E Bertini; G Salviati; F Apollo; E Ricci; S Servidei; A Broccolini; M Papacci; P Tonali
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  Exciting perspectives for Translational Myology in the Abstracts of the 2018Spring PaduaMuscleDays: Giovanni Salviati Memorial - Chapter I - Foreword.

Authors:  Ugo Carraro
Journal:  Eur J Transl Myol       Date:  2018-02-20

10.  Restrictive Cardiomyopathy is Caused by a Novel Homozygous Desmin (DES) Mutation p.Y122H Leading to a Severe Filament Assembly Defect.

Authors:  Andreas Brodehl; Seyed Ahmad Pour Hakimi; Caroline Stanasiuk; Sandra Ratnavadivel; Doris Hendig; Anna Gaertner; Brenda Gerull; Jan Gummert; Lech Paluszkiewicz; Hendrik Milting
Journal:  Genes (Basel)       Date:  2019-11-11       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.